BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19415813)

  • 1. An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes.
    Balci S; Engiz O; Erekul A; Gozdasoglu S; Vulliamy T
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):607-8. PubMed ID: 19415813
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskeratosis congenita.
    Handley TP; McCaul JA; Ogden GR
    Oral Oncol; 2006 Apr; 42(4):331-6. PubMed ID: 16140563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskeratosis congenita: a genetic disorder of many faces.
    Kirwan M; Dokal I
    Clin Genet; 2008 Feb; 73(2):103-12. PubMed ID: 18005359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.
    de la Fuente J; Dokal I
    Pediatr Transplant; 2007 Sep; 11(6):584-94. PubMed ID: 17663679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase RNA structure and function: implications for dyskeratosis congenita.
    Chen JL; Greider CW
    Trends Biochem Sci; 2004 Apr; 29(4):183-92. PubMed ID: 15082312
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations of telomerase complex genes linked to bone marrow failures.
    Yamaguchi H
    J Nippon Med Sch; 2007 Jun; 74(3):202-9. PubMed ID: 17625368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations of the DKC1 gene in individuals affected with dyskeratosis congenita.
    Rostamiani K; Klauck SM; Heiss N; Poustka A; Khaleghi M; Rosales R; Metzenberg AB
    Blood Cells Mol Dis; 2010; 44(2):88. PubMed ID: 19879169
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a novel mutation in DKC1 in dyskeratosis congenita.
    Kurnikova M; Shagina I; Khachatryan L; Schagina O; Maschan M; Shagin D
    Pediatr Blood Cancer; 2009 Jan; 52(1):135-7. PubMed ID: 18802941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice.
    He J; Navarrete S; Jasinski M; Vulliamy T; Dokal I; Bessler M; Mason PJ
    Oncogene; 2002 Oct; 21(50):7740-4. PubMed ID: 12400016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow failure due to telomere associated gene mutation].
    Yamaguchi H; Dan K
    Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow failure due to telomerase complex gene mutations].
    Yamaguchi H
    Rinsho Ketsueki; 2006 Nov; 47(11):1431-7. PubMed ID: 17176885
    [No Abstract]   [Full Text] [Related]  

  • 13. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita.
    Hiramatsu H; Fujii T; Kitoh T; Sawada M; Osaka M; Koami K; Irino T; Miyajima T; Ito M; Sugiyama T; Okuno T
    Pediatr Hematol Oncol; 2002 Sep; 19(6):413-9. PubMed ID: 12186364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome.
    Yaghmai R; Kimyai-Asadi A; Rostamiani K; Heiss NS; Poustka A; Eyaid W; Bodurtha J; Nousari HC; Hamosh A; Metzenberg A
    J Pediatr; 2000 Mar; 136(3):390-3. PubMed ID: 10700698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.
    Vieri M; Kirschner M; Tometten M; Abels A; Rolles B; Isfort S; Panse J; Brümmendorf TH; Beier F
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita--two siblings with a new missense mutation in the DKC1 gene.
    Coelho JD; Lestre S; Kay T; Lopes MJ; Fiadeiro T; Apetato M
    Pediatr Dermatol; 2011; 28(4):464-6. PubMed ID: 21736606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
    Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases.
    Dvorak LA; Vassallo R; Kirmani S; Johnson G; Hartman TE; Tazelaar HD; Leslie KO; Colby TV; Cockcroft DW; Churg AM; Yi ES
    Hum Pathol; 2015 Jan; 46(1):147-52. PubMed ID: 25455995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita.
    Kanegane H; Kasahara Y; Okamura J; Hongo T; Tanaka R; Nomura K; Kojima S; Miyawaki T
    Br J Haematol; 2005 May; 129(3):432-4. PubMed ID: 15842668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.